Annovis Bio, Inc.: Annovis Bio to Participate at the Benzing

(1)
Berwyn, Pennsylvania--(Newsfile Corp. - May 11, 2021) - Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative diseases, today announced that management will participate at the Benzinga Global Small Cap Conference taking place online May 13-14, 2021.
Annovis Bio CEO Maria Maccecchini, Ph.D. will deliver a corporate presentation at 3:10 p.m. ET on May 13, 2021.
Investors can request a one-on-one meeting with Dr. Maccecchini and Annovis Bio CFO Jeff McGroarty using the networking feature within the virtual conference platform.
To register for the conference, visit: https://www.benzinga.com/events/small-cap/global/

Related Keywords

Berwyn , Pennsylvania , United States , American , Maria Maccecchini , Jeff Mcgroarty , Annovis Bio , Exchange Commission , Pennsylvania Newsfile Corp , Annovis Bio Inc , Redchip Companies Inc , Benzinga Global Small Cap Conference , Down Syndrome , Annual Report , பெர்வின் , பென்சில்வேனியா , ஒன்றுபட்டது மாநிலங்களில் , அமெரிக்கன் , ஜெஃப் ம்க்கிரிோஆறுத்தி , பரிமாற்றம் தரகு , கீழ் நோய்க்குறி , ஆண்டு அறிக்கை ,